Dunhill Financial’s Globus Medical GMED Stock Holding History

Dunhill Financial’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1	Closed	-$135	–	1740
2026 Q1	$135	Sell	1 -1	-50%	-$90	﹤0.01%	1325
2025 Q4	$138	Buy	+2	New	+$152	﹤0.01%	1243

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Dunhill Financial's GMED Position: Q2 2026 in Review

Dunhill Financial sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 1 share — an estimated $135 sold.

Dunhill Financial first reported a position in GMED in Q4 2025 and held it in 2 quarters. The position peaked at $138 in Q4 2025. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Dunhill Financial reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
Dunhill Financial sold 1 Globus Medical share in Q2 2026, an estimated $135.
Dunhill Financial first reported a position in Globus Medical in Q4 2025 and held it in 2 quarters.
Dunhill Financial's Globus Medical position peaked at $138 in Q4 2025.
596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.